CRISPR Therapeutics CRSP Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $347.56M+16.5% | $298.26M-23.4% | $389.48M+83.8% | $211.89M-77.0% | ||
| $1.63B+1.4% | $1.61B+23.1% | $1.3B-18.7% | $1.6B+10.1% | ||
| $0-100% | $25M-87.5% | $200M— | $0-100% | ||
| $1.99B+2.5% | $1.94B+1.5% | $1.91B+3.0% | $1.85B-23.3% | ||
| $115.85M-13.6% | $134.09M-11.7% | $151.95M-7.1% | $163.63M+18.9% | ||
| $2.27B+1.0% | $2.24B+0.6% | $2.23B-0.6% | $2.24B-18.5% | ||
| $11.14M-24.3% | $14.71M-61.4% | $38.15M+39.1% | $27.43M+85.1% | ||
| $15.77M+310% | $3.85M-6.3% | $4.11M— | $0-100% | ||
| $149.12M+69.9% | $87.78M-19.3% | $108.79M-10.2% | $121.11M+1.0% | ||
| $0— | —— | —— | —— | ||
| $343.43M+10.8% | $309.95M-10.6% | $346.77M-5.7% | $367.58M+4.3% | ||
| $3.09M+14.4% | $2.7M+8.0% | $2.5M+2.3% | $2.44M+2.1% | ||
| -$1.95B-42.6% | -$1.37B-36.6% | -$999.7M-18.2% | -$846.09M-332% | ||
| $1.92B-0.5% | $1.93B+2.6% | $1.88B+0.4% | $1.88B-21.8% | ||
| $2.27B+1.0% | $2.24B+0.6% | $2.23B-0.6% | $2.24B-18.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are CRISPR Therapeutics's total assets?
- CRISPR Therapeutics (CRSP) holds $2.7B in total assets, up 25.8% year over year.
- How much debt does CRISPR Therapeutics have?
- CRISPR Therapeutics carries $787.6M in total debt against $1.8B of shareholders' equity, a debt-to-equity ratio of 0.43.
- How much cash does CRISPR Therapeutics have?
- CRISPR Therapeutics holds $423.3M in cash and equivalents.
- Can CRISPR Therapeutics cover its short-term obligations?
- Its current ratio is 17.96 — current assets exceed current liabilities.
- Where does CRISPR Therapeutics's balance sheet data come from?
- Every line is extracted from CRISPR Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
